SapnaPPatelMD

PubMed

• Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.
  Isabella C Glitza Oliva, Sherise D Ferguson, Roland Bassett Jr, Alexandra P Foster, Ida John, Tarin D Hennegan, Michelle Rohlfs, Jessie Richard, Masood Iqbal, Tina Det...> ;Nature Medicine. 2024 Apr 22
• Multicentre analysis of nucleic acid quantification using aqueous humour liquid biopsy in uveal melanoma: implications for clinical testing.
  Sarah B Pike, Mark W Reid, Chen-Ching Peng, Christina Chang, Dan S Gombos, Sapna Patel, Liya Xu, Benjamin Y Xu, Jesse L Berry> ;Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2023 Nov 27
• 1 citations
  Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors.
  Yibirin, M., Mustafayev, K., Hosry, J., Pundhir, P., Klingen, J., Yepez Guevara, E., Granwehr, B., Kaseb, A., Naing, A., Patel, S., Shah, A., Skoulidis, F., Tawbi, H.,...> ;The American Journal of Gastroenterology. 2023 Sep 1
• 4 citations
  T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy.
  Bettzy Stephen, Joud Hajjar, Shrutii Sarda, Dzifa Yawa Duose, Jeffrey M Conroy, Carl Morrison, Anas Alshawa, Mingxuan Xu, Abdulrazzak Zarifa, Sapna P Patel, Ying Yuan,...> ;Journal for Immunotherapy of Cancer. 2023 Aug 1
• Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma.
  Anthony Lucci, Sridevi Addanki, Yi-Ju Chiang, Salyna Meas, Vanessa N Sarli, Joshua R Upshaw, Mayank Manchem, Sapna P Patel, Jennifer A Wargo, Jeffrey E Gershenwald, Me...> ;Cancers. 2023 Jul 15
• Minority enrollment in melanoma clinical trials.
  Elena Paz Munoz, Sapna P Patel, Sancy A Leachman, Nathan Y Yu, Wesley Y Yu> ;Journal of the American Academy of Dermatology. 2023 Nov 1
• 11 citations
  Neoadjuvant immunotherapy for melanoma is now ready for clinical practice.
  Claus Garbe, Reinhard Dummer, Teresa Amaral, Rodabe N Amaria, Paolo A Ascierto, Elizabeth M Burton, Brigitte Dreno, Alexander M M Eggermont, Axel Hauschild, Christoph ...> ;Nature Medicine. 2023 Jun 1
• 14 citations
  Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.
  Isabella C Glitza Oliva, Sherise D Ferguson, Roland Bassett Jr, Alexandra P Foster, Ida John, Tarin D Hennegan, Michelle Rohlfs, Jessie Richard, Masood Iqbal, Tina Det...> ;Nature Medicine. 2023 Apr 1
• 1 citations
  Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.
  Mirella Nardo, Bulent Yilmaz, Blessie Elizabeth Nelson, Harrys A Torres, Lan Sun Wang, Bruno Palma Granwehr, Juhee Song, Hanna R F Dalla Pria, Van A Trinh, Isabella C ...> ;The Oncologist. 2023 Aug 3
• 1 citations
  Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
  Rodabe N Amaria, Michael Postow, Elizabeth M Burton, Michael T Tetzlaff, Merrick I Ross, Carlos Torres-Cabala, Isabella C Glitza, Fei Duan, Denái R Milton, Klaus Busam...> ;Nature. 2023 Mar 1
• 123 citations
  Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
  Sapna P Patel, Megan Othus, Yuanbin Chen, G Paul Wright Jr, Kathleen J Yost, John R Hyngstrom, Siwen Hu-Lieskovan, Christopher D Lao, Leslie A Fecher, Thach-Giao Truon...> ;The New England Journal of Medicine. 2023 Mar 2
• New evidence for neoadjuvant therapy in advanced melanoma.
  Sapna P Patel> ;Clinical Advances in Hematology & Oncology. 2023 Mar 1
• 33 citations
  Advances in the clinical management of uveal melanoma.
  Richard D Carvajal, Joseph J Sacco, Martine J Jager, David J Eschelman, Roger Olofsson Bagge, J William Harbour, Nicholas D Chieng, Sapna P Patel, Anthony M Joshua, So...> ;Nature Reviews. Clinical Oncology. 2023 Feb 1
• Editorial: Women in skin cancer vol II: 2022.
  Selma Ugurel, Sapna P Patel> ;Frontiers in Oncology. 2023 Jan 1
• 6 citations
  Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth.
  Chandrani Chattopadhyay, Rajat Bhattacharya, Jason Roszik, Fatima S Khan, Gabrielle A Wells, Hugo Villanueva, Yong Qin, Rishav Bhattacharya, Sapna P Patel, Elizabeth A...> ;Cancers. 2022 Dec 19
• Novel treatment paradigms for metastatic uveal melanoma.
  Sapna P Patel, Steven C Katz> ;Cancer Gene Therapy. 2022 Dec 1
• 1 citations
  Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of ...
  Joseph M Unger, Amy Darke, Megan Othus, Thach-Giao Truong, Nikhil Khushalani, Kari Kendra, Karl D Lewis, Bryan Faller, Pauline Funchain, Elizabeth I Buchbinder, Ahmad ...> ;JAMA Oncology. 2023 Feb 1
• 102 citations
  Neoadjuvant relatlimab and nivolumab in resectable melanoma.
  Rodabe N Amaria, Michael Postow, Elizabeth M Burton, Michael T Tetzlaff, Merrick I Ross, Carlos Torres-Cabala, Isabella C Glitza, Fei Duan, Denái R Milton, Klaus Busam...> ;Nature. 2022 Nov 1
• 36 citations
  Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
  Christopher P Vellano, Michael G White, Miles C Andrews, Manoj Chelvanambi, Russell G Witt, Joseph R Daniele, Mark Titus, Jennifer L McQuade, Fabio Conforti, Elizabeth...> ;Nature. 2022 Jun 1
• 3 citations
  Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.
  Caitlin A Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, Tatiana Karpinets, Katarzyna Tomczak, Chip Stewart, Carlos A Torres-Cabala, Shari Pilon-Thomas, Amod A Sarnai...> ;Clinical Cancer Research. 2022 May 2
• 34 citations
  Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy.
  Sang T Kim, Yanshuo Chu, Mercy Misoi, Maria E Suarez-Almazor, Jean H Tayar, Huifang Lu, Maryam Buni, Jordan Kramer, Emma Rodriguez, Zulekha Hussain, Sattva S Neelapu, ...> ;Nature Communications. 2022 Apr 12
• 3 citations
  25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions.
  Thach-Giao Truong, Lucy Boyce Kennedy, Sapna P Patel> ;Current Oncology Reports. 2022 Apr 1
• 6 citations
  The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signaling.
  Max O Meneveau, Pankaj Kumar, Kevin T Lynch, Sapna P Patel, Craig L Slingluff> ;Journal for Immunotherapy of Cancer. 2022 Mar 1
• 3 citations
  Second Primary Malignancies in Patients With Melanoma Subtypes: Analysis of 120,299 Patients From the SEER Database (2000-2016).
  Asad Loya, Dan S Gombos, Sapna P Patel> ;Frontiers in Oncology. 2022 Jan 1
• 12 citations
  Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.
  Joel Ho, Jane Mattei, Michael Tetzlaff, Michelle D Williams, Michael A Davies, Adi Diab, Isabella C Glitza Oliva, Jennifer McQuade, Sapna P Patel, Hussein Tawbi, Micha...> ;Frontiers in Oncology. 2022 Jan 1
• Join now to see all

Journal Articles

• Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
  Scott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
• Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
  Janice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
• Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
  Richard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature